Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 2

Results: 12
    1

    Response to comment on "International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"

    Published in:
    Pharmacotherapy, 2024, v. 44, n. 2, p. 208, doi. 10.1002/phar.2907
    By:
    • Hong, Lisa T.;
    • Downes, Kevin J.;
    • FakhriRavari, Alireza;
    • Abdul‐Mutakabbir, Jacinda C.;
    • Kuti, Joseph L.;
    • Jorgensen, Sarah;
    • Young, David C.;
    • Alshaer, Mohammad H.;
    • Bassetti, Matteo;
    • Bonomo, Robert A.;
    • Gilchrist, Mark;
    • Jang, Soo Min;
    • Lodise, Thomas;
    • Roberts, Jason A.;
    • Tängdén, Thomas;
    • Zuppa, Athena;
    • Scheetz, Marc H.
    Publication type:
    Article
    2

    "Comment on 'international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists'"

    Published in:
    Pharmacotherapy, 2024, v. 44, n. 2, p. 207, doi. 10.1002/phar.2906
    By:
    • Espinoza Cobeñas, Carlos Augusto
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Issue Information.

    Published in:
    Pharmacotherapy, 2024, v. 44, n. 2, p. 107, doi. 10.1002/phar.2691
    Publication type:
    Article
    12